Diagnosis and treatment of deep-vein thrombosis

Deep-vein thrombosis (DVT) is a common condition that can lead to complications such as postphlebitic syndrome, pulmonary embolism and death. The approach to the diagnosis of DVT has evolved over the years. Currently an algorithm strategy combining pretest probability, D-dimer testing and compression ultrasound imaging allows for safe and convenient investigation of suspected lower-extremity thrombosis. Patients with low pretest probability and a negative D-dimer test result can have proximal DVT excluded without the need for diagnostic imaging. The mainstay of treatment of DVT is anticoagulation therapy, whereas interventions such as thrombolysis and placement of inferior vena cava filters are reserved for special situations. The use of low-molecular-weight heparin allows for outpatient management of most patients with DVT. The duration of anticoagulation therapy depends on whether the primary event was idiopathic or secondary to a transient risk factor. More research is required to optimally define the factors that predict an increased risk of recurrent DVT to determine which patients can benefit from extended anticoagulant therapy.

[1]  S. Doucette,et al.  Does this patient have deep vein thrombosis? , 1998, JAMA.

[2]  S. Eichinger D-Dimer Testing in Pregnancy , 2003, Pathophysiology of Haemostasis and Thrombosis.

[3]  D. Ost,et al.  Duration of anticoagulation following venous thromboembolism: a meta-analysis. , 2005, JAMA.

[4]  L. Bressollette Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary Embolism: The PREPIC (Prévention du Risque d’Embolie Pulmonaire par Interruption Cave) Randomized Study , 2005, Circulation.

[5]  M. Prins,et al.  Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome , 2005, Journal of thrombosis and haemostasis : JTH.

[6]  F. García-Bragado,et al.  The influence of extreme body weight on clinical outcome of patients with venous thromboembolism: findings from a prospective registry (RIETE) , 2005, Journal of thrombosis and haemostasis : JTH.

[7]  T. Barbui,et al.  A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS) 1 , 2005, Journal of thrombosis and haemostasis : JTH.

[8]  I. Greer,et al.  Low molecular weight heparin in pregnancy: current issues , 2005, British journal of haematology.

[9]  M. Boulvain,et al.  D‐dimer levels during delivery and the postpartum , 2005, Journal of thrombosis and haemostasis : JTH.

[10]  M. Kovacs,et al.  The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients , 2005, Journal of thrombosis and haemostasis : JTH.

[11]  S. Money,et al.  Low-Molecular-Weight Heparin Versus Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients With Cancer , 2004 .

[12]  G. Raskob,et al.  Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis , 2004, Annals of Internal Medicine.

[13]  Paolo Prandoni,et al.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.

[14]  S. Kahn,et al.  Relationship between deep venous thrombosis and the postthrombotic syndrome. , 2004, Archives of internal medicine.

[15]  Jonathan Dreyer,et al.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. , 2003, The New England journal of medicine.

[16]  J. Douketis,et al.  A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. , 2003, The New England journal of medicine.

[17]  T. Baglin,et al.  Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study , 2003, The Lancet.

[18]  M. Gent,et al.  Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. , 2003, The New England journal of medicine.

[19]  M. Prins,et al.  Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. , 2003, The New England journal of medicine.

[20]  J. Douketis,et al.  A Diagnostic Strategy Involving a Quantitative Latex d-Dimer Assay Reliably Excludes Deep Venous Thrombosis , 2003, Annals of Internal Medicine.

[21]  G. Kovacs,et al.  Combined use of clinical assessment and d‐dimer to improve the management of patients presenting to the emergency department with suspected deep vein thrombosis (the EDITED Study) , 2003, Journal of thrombosis and haemostasis : JTH.

[22]  A. Folsom,et al.  Fibrin fragment D-dimer and the risk of future venous thrombosis. , 2003, Blood.

[23]  M. Prins,et al.  Once versus twice daily LMWH for the initial treatment of venous thromboembolism. , 2003, The Cochrane database of systematic reviews.

[24]  D. Coyle,et al.  The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy. , 2003, Thrombosis research.

[25]  M. Prins,et al.  Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism , 2002, Annals of Internal Medicine.

[26]  Paolo Prandoni,et al.  Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. , 2002, Blood.

[27]  A. Rudd,et al.  Plasma D-dimers in the diagnosis of venous thromboembolism. , 2002, Archives of internal medicine.

[28]  M. Petri Management of thrombosis in antiphospholipid antibody syndrome. , 2001, Rheumatic diseases clinics of North America.

[29]  A. Forster,et al.  Thrombolysis in Deep Vein Thrombosis: Is there still an Indication? , 2001, Thrombosis and Haemostasis.

[30]  D. Anderson,et al.  Effect of Patient Weight on the Anticoagulant Response to Adjusted Therapeutic Dosage of Low-Molecular- Weight Heparin for the Treatment ofVenous Thromboembolism , 2001, Pathophysiology of Haemostasis and Thrombosis.

[31]  A. Forster,et al.  Tissue plasminogen activator for the treatment of deep venous thrombosis of the lower extremity: a systematic review. , 2001, Chest.

[32]  H. Bounameaux,et al.  Comparison of four strategies for diagnosing deep vein thrombosis: a cost-effectiveness analysis. , 2001, The American journal of medicine.

[33]  P. Prandoni,et al.  Upper Extremity Deep Vein Thrombosis: Risk Factors, Diagnosis, and Management , 2001, Seminars in vascular medicine.

[34]  C. Kearon Noninvasive diagnosis of deep vein thrombosis in postoperative patients. , 2001, Seminars in thrombosis and hemostasis.

[35]  M Stain,et al.  High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. , 2000, The New England journal of medicine.

[36]  D. Anderson,et al.  Diagnosis of deep-vein thrombosis in the year 2000 , 2000, Current opinion in pulmonary medicine.

[37]  H. Eriksson,et al.  Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. , 2000, Archives of internal medicine.

[38]  Lain,et al.  A CLINICAL TRIAL OF VENA CAVAL FILTERS IN THE PREVENTION OF PULMONARY EMBOLISM IN PATIENTS WITH PROXIMAL DEEP-VEIN THROMBOSIS , 2000 .

[39]  M. Prins,et al.  Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. , 2000, The Cochrane database of systematic reviews.

[40]  G Leone,et al.  The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. , 1999, The New England journal of medicine.

[41]  J. Hirsh,et al.  Prognosis in acute pulmonary embolism , 1999, The Lancet.

[42]  M. Kovacs,et al.  Dalteparin in emergency patients to prevent admission prior to investigation for venous thromboembolism. , 1999, The American journal of emergency medicine.

[43]  P. Wells,et al.  Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection. , 1998, Archives of internal medicine.

[44]  M. Math,et al.  Noninvasive Diagnosis of Deep Venous Thrombosis , 1998, Annals of Internal Medicine.

[45]  W M O'Fallon,et al.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.

[46]  F. Barral,et al.  A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. , 1998, The New England journal of medicine.

[47]  P. Prandoni,et al.  Long-term outcomes after deep venous thrombosis of the lower extremities , 1998, Vascular medicine.

[48]  H. Büller,et al.  Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study , 1998, BMJ.

[49]  Janis Bormanis,et al.  Value of assessment of pretest probability of deep-vein thrombosis in clinical management , 1997, The Lancet.

[50]  O. Linder,et al.  The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. , 1997, The New England journal of medicine.

[51]  P. Bossuyt,et al.  Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. , 1996, The New England journal of medicine.

[52]  J. Hirsh,et al.  A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. , 1996, The New England journal of medicine.

[53]  M. Gent,et al.  Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis , 1995, Thrombosis and Haemostasis.

[54]  Olle Linder,et al.  A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism , 1995 .

[55]  K. Schulman,et al.  Cost-effectiveness analyses. , 1995, The New England journal of medicine.

[56]  S. Schulman,et al.  A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism , 1996 .

[57]  J. Hirsh,et al.  Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery , 1995, Annals of Internal Medicine.

[58]  H. Heijboer A Comparison of Real-Time Compression Ultrasonography With Impedance Plethysmography for the Diagnosis of Deep-Vein Thrombosis in Symptomatic Outpatients , 1994 .

[59]  H. Büller,et al.  A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. , 1993, The New England journal of medicine.

[60]  H R Büller,et al.  Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. , 1992, The New England journal of medicine.

[61]  H. Büller,et al.  Clinical Utility of Real-Time Compression Ultrasonography for Diagnostic Management of Patients with Recurrent Venous Thrombosis , 1992, Acta radiologica.

[62]  B E Hillner,et al.  Optimal management of suspected lower-extremity deep vein thrombosis. An evaluation with cost assessment of 24 management strategies. , 1992, Archives of internal medicine.

[63]  E. G. Moss,et al.  Noninvasive diagnosis of deep vein thrombosis. , 1990, New Jersey medicine : the journal of the Medical Society of New Jersey.

[64]  G. Raskob,et al.  Serial impedance plethysmography in pregnant patients with clinically suspected deep‐vein thrombosis. Clinical validity of negative findings , 1990, Annals of internal medicine.

[65]  G. Raskob,et al.  Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. , 1982, The New England journal of medicine.